• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; AFX2 BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; AFX2 BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA25-110/I20-30
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Aneurysm (1708); Failure of Implant (1924); Rupture (2208)
Date of Event 02/24/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in the event was explanted but will not be returned for evaluation.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2 with duraply.
 
Event or Problem Description
The patient was initially implanted with a afx2 bifurcated stent graft, and a vela suprarenal aortic extension to treat an abdominal aortic aneurysm (aaa).Approximately 3.5 years post initial implant, the patient presented emergently with a ruptured aneurysm.The physician elected to preform an open repair/ explant to resolve this event.Reportedly, the patient was in a moving vehicle accident (mva) and the physician believes the accident may have played a part in the ruptured aneurysm.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.There are no other equivalent adverse events/incidents for this lot number existing within the endologix complaint handling system.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it was discarded at the user facility.A clinical evaluation of the adverse event/incident could not be completed.No medical records nor medical imaging relevant to the reported adverse event/incident was received by endologix.The user facility was unable to provide this information.Due to the absence of medical records and medical imaging; device, use, procedure, and/or anatomy relatedness to this adverse event/incident could not be evaluated.It was reported the patient had a recent motor vehicle accident.It is unclear if this contributed to the reported event.The final patient status was reported to be doing well following a secondary endovascular procedure.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.Corrections: h6: result code: remove code 3233.H6: conclusion code: remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
AFX2 BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key11499669
Report Number2031527-2021-00139
Device Sequence Number19578137
Product Code MIH
UDI-Device Identifier00818009014818
UDI-Public(01)00818009014818(17)170808
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2021
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 02/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/08/2017
Device Model NumberBEA25-110/I20-30
Device Lot Number1560319011
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/24/2021
Supplement Date Received by Manufacturer02/24/2021
Initial Report FDA Received Date03/16/2021
Supplement Report FDA Received Date04/27/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
VELA SUPRARENAL, LOT#1587565010
Outcome Attributed to Adverse Event Required Intervention;
Patient Age67 YR
-
-